scholarly article | Q13442814 |
P356 | DOI | 10.1002/HON.2306 |
P698 | PubMed publication ID | 27283119 |
P50 | author | Nathalie Steimberg | Q43122105 |
Giovanna Mazzoleni | Q55860441 | ||
Luisa Pascucci | Q56250327 | ||
P2093 | author name string | Valeria Sordi | |
Angiola Berenzi | |||
Anna Benetti | |||
Arianna Bonomi | |||
Augusto Pessina | |||
Giulio Alessandri | |||
Valentina Coccè | |||
Jennifer Boniotti | |||
P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
Clinical use of proteasome inhibitors in the treatment of multiple myeloma | Q28080999 | ||
Ex-vivo dynamic 3-D culture of human tissues in the RCCS™ bioreactor allows the study of Multiple Myeloma biology and response to therapy | Q28535634 | ||
Advances in the understanding of myeloma bone disease and tumour growth | Q33829022 | ||
Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy | Q34113542 | ||
Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth | Q34741694 | ||
Stem cell transplantation for multiple myeloma | Q35692626 | ||
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth | Q36092153 | ||
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. | Q36733492 | ||
The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles | Q36842444 | ||
The pharmacological bases of the antiangiogenic activity of paclitaxel | Q36927558 | ||
New therapies in multiple myeloma. | Q36986576 | ||
Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? | Q37124172 | ||
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway | Q37372102 | ||
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets. | Q37484765 | ||
Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? | Q37833578 | ||
Fibroblasts maintained in 3 dimensions show a better differentiation state and higher sensitivity to estrogens | Q38961393 | ||
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery | Q38969541 | ||
Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity | Q39094393 | ||
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles | Q39445337 | ||
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
MRT Letter: 3D culture of isolated cells: A fast and efficient method for optimizing their histochemical and immunocytochemical analyses | Q61386768 | ||
Structural analysis of rat bone explants kept in vitro in simulated microgravity conditions | Q61386796 | ||
P433 | issue | 4 | |
P921 | main subject | multiple myeloma | Q467635 |
P304 | page(s) | 693-702 | |
P577 | publication date | 2016-06-10 | |
P1433 | published in | Hematological Oncology | Q15762617 |
P1476 | title | Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system | |
P478 | volume | 35 |
Q57215522 | 3d Tissue Engineered In Vitro Models Of Cancer In Bone |
Q91658925 | Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities |
Q58760128 | Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth |
Q52608756 | Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. |
Q52679939 | Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T-cell immune responses via PD-1/PD-L1 pathway. |
Q52591382 | Dental pulp stem cells used to deliver the anticancer drug paclitaxel. |
Q92798740 | Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities |
Q47821722 | Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery. |
Q98466507 | Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer |
Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
Q92081475 | The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy |
Search more.